Literature DB >> 6130023

Inhibitory effect of prolonged administration of long-acting somatostatin on gastrin-stimulated fundic epithelial cell growth in the rat.

T Lehy, M Dubrasquet, P Brazeau, S Bonfils.   

Abstract

The effects of a 3-week administration of long-acting somatostatin were explored (a) in young rats under both normal and long-acting gastrin stimulation and (b) in adult rats with transposition of the antrum onto the colon and, therefore, chronically stimulated with endogenous gastrin. Histomorphometric parameters of the fundic mucosa were estimated at the end of the treatment. In young rats, somatostatin alone (390 micrograms/kg/day) only lowered parietal and peptic cell densities per cubic millimeter compared to controls. That it exerted an antitropic effect under physiological conditions remains questionable. However, in cases of chronic hypergastrinemia, the same dose of somatostatin obviously antagonized the growth-promoting effect of exogenous or endogenous gastrin.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6130023     DOI: 10.1159/000198804

Source DB:  PubMed          Journal:  Digestion        ISSN: 0012-2823            Impact factor:   3.216


  3 in total

1.  New somatostatin molecule for management of endocrine tumours.

Authors:  S Bonfils
Journal:  Gut       Date:  1985-05       Impact factor: 23.059

2.  Treatment of patients with pancreatic endocrine tumours using a new long-acting somatostatin analogue symptomatic and peptide responses.

Authors:  S M Wood; M E Kraenzlin; T E Adrian; S R Bloom
Journal:  Gut       Date:  1985-05       Impact factor: 23.059

3.  Epithelial response of the rat gastric mucosa to chronic superficial injury.

Authors:  E R Lacy; K S Cowart; J S King; J DelValle; A J Smolka
Journal:  Yale J Biol Med       Date:  1996 Mar-Apr
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.